Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions

Table 1

Demographic and comorbidity details of patients.

Patients	Height (cm)	Age (yr)	Body weight (kg)	History of psoriasis (yr)	Comorbid condition	Previous therapy
Patient 1	165.1	45	65	10	Psoriatic arthritis	Emollient, cyclosporine, and methotrexate
Patient 2	162.6	62	75	11	Type 2 diabetes with hypertension	Emollient and methotrexate
Patient 3	135.1	50	76	12	Interstitial lung disease	Emollient, cyclosporine, and methotrexate
Patient 4	160.0	63	80	10	Alcoholic liver disease	Emollient, cyclosporine, and methotrexate
Patient 5	135.1	35	60	6	Hypertension	Emollient and methotrexate
Patient 6	170.2	35	65	8	Hypertension	Emollient and methotrexate
Patient 7	152.4	59	67	13	Type 2 diabetes with hypertension	Emollient and methotrexate